Real relief. Real science.

Pioneering Neuro-Therapeutics

CBX Therapeutics is dedicated to developing cutting-edge, evidence-based cannabinoid formulations. Our focus is on developing a product for immediate relief for tremors today, while simultaneously working towards advanced neuroprotection for a healthier future. We blend rigorous science with natural compounds to address pressing neurological needs.

Our Solution

CLARIFY - Discovery Platform

Combinatorial Discovery

Rigorous Funneling

Predictive Modeling

Translational Output

1st Lead Asset CLARIFY(ied)

Fast-acting oral disintegrating tablet for Parkinson's patients

Portfolio

TPP-1

Fast-acting ODT for Parkinsonian tremor (2 regulatory variants).

TPP-2

Neuroprotection solution addressing broader neurological wellness.

TPP-3

Novel target for disease modifying mechanism.

Our Edge: What Makes CBX Different

We plan and execute…

Dr. Shimon Lecht

Founder & CEO

  • Scientist–entrepreneur
  • Business strategy
  • Translational R&D

Eliyahu Shalom

Co-Founder & Director

  • Venture building
  • Business development
  • Operations & Finance

Dr. Tatiana Zvagelsky

Head of R&D

  • Research & Discovery
  • Analytics & Quality
  • Project management

Daniel Abrahami

US Commercial Lead

  • Go-to-market strategy
  • Channel partnerships
  • Growth operations

Trusted by our investors:

Real people are suffering.


Let’s keep doing the hard work that matters, together.

Real relief. Real science.

info@cbxtx.com


© 2025 CBX Therapeutics Ltd.